Philip D Greenberg Selected Research

Philip D Greenberg Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 06/2002
13	Leukemia 01/2019 - 03/2006
7	Adenocarcinoma 01/2022 - 07/2014
6	Virus Diseases (Viral Diseases) 09/2017 - 04/2003
6	Infections 10/2016 - 03/2004
5	Wilms Tumor (Wilm's Tumor) 01/2022 - 07/2007
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2011
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2014
3	Persistent Infection 10/2016 - 04/2007
3	Lymphoma (Lymphomas) 04/2012 - 05/2005
2	COVID-19 01/2022 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2014
2	Viremia 01/2022 - 04/2004
2	Melanoma (Melanoma, Malignant) 11/2016 - 01/2016
2	Carcinogenesis 01/2016 - 10/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	VLCAD deficiency 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019
1	Inflammation (Inflammations) 04/2016
1	Liver Neoplasms (Liver Cancer) 01/2016
1	Human Influenza (Influenza) 09/2012
1	Testicular Neoplasms (Testicular Cancer) 06/2012
1	Autoimmune Diseases (Autoimmune Disease) 02/2012
1	Multiple Myeloma 02/2011
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2008
1	Coinfection 08/2004
1	HIV Infections (HIV Infection) 09/2003

Drug/Important Bio-Agent (IBA)

25	AntigensIBA 01/2022 - 06/2002
13	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 05/2008
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
7	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 05/2004
6	AutoantigensIBA 12/2017 - 03/2006
4	EpitopesIBA 01/2022 - 05/2004
4	CytokinesIBA 01/2022 - 08/2004
4	MesothelinIBA 01/2022 - 01/2019
4	Peptides (Polypeptides)IBA 01/2022 - 05/2004
4	Interleukin-2 (IL2)IBA 11/2017 - 09/2003
4	VaccinesIBA 08/2011 - 04/2004
3	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2017
3	Chimeric Antigen ReceptorsIBA 04/2012 - 09/2008
2	fas Receptor (CD95 Antigen)IBA 01/2022 - 12/2020
2	AntibodiesIBA 01/2022 - 10/2016
2	Fas Ligand Protein (Fas Ligand)IBA 01/2022 - 12/2020
2	Interferon Type IIBA 10/2016 - 10/2016
2	Antiviral Agents (Antivirals)IBA 10/2016 - 10/2016
2	Biological ProductsIBA 11/2014 - 05/2003
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	WT1 ProteinsIBA 01/2022
1	LuciferasesIBA 01/2021
1	LipidsIBA 01/2020
1	LigandsIBA 01/2019
1	Granzymes (Granzyme)IBA 01/2019
1	IpilimumabIBA 11/2016
1	InterferonsIBA 10/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016
1	Pathogen-Associated Molecular Pattern MoleculesIBA 04/2016
1	carboxypolymethyleneIBA 04/2016
1	Tamoxifen FDA LinkGeneric 01/2016
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2013
1	HLA-A*02:01 antigenIBA 02/2013
1	Transcription Factors (Transcription Factor)IBA 02/2013
1	Hemagglutinins (Hemagglutinin)IBA 09/2012
1	Glycoproteins (Glycoprotein)IBA 09/2012
1	Small Interfering RNA (siRNA)IBA 08/2012
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2012
1	Zinc Finger NucleasesIBA 05/2012
1	ProMune (CpG 7909)IBA 02/2011
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2008
1	Neomycin FDA LinkGeneric 09/2008
1	gag Gene Products (gag Protein)IBA 08/2008
1	Viral ProteinsIBA 05/2008
1	OligodeoxyribonucleotidesIBA 04/2007
1	Interleukin-15 (Interleukin 15)IBA 03/2006
1	RNA (Ribonucleic Acid)IBA 05/2004
1	Protein Subunits (Protein Subunit)IBA 04/2004
1	DNA (Deoxyribonucleic Acid)IBA 04/2004

Therapy/Procedure

25	Therapeutics 01/2022 - 03/2006
16	Immunotherapy 01/2022 - 05/2003
2	Cell Transplantation 01/2019 - 02/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Hysterectomy 01/2021
1	Salpingo-oophorectomy 01/2021
1	Drug Therapy (Chemotherapy) 11/2015
1	Intranasal Administration 09/2012
1	Stem Cell Transplantation 06/2012
1	Transplantation 03/2006